Urotensin-II (UII) is a vasoactive peptide that promotes vascular smooth muscle cells (VSMCs) proliferation and is involved in the pathogenesis of atherosclerosis, restenosis, and vascular remodelling. This study aimed to determine the role of calcium (Ca 2+ )-dependent signalling and alternative signalling pathways in UII-evoked VSMCs proliferation focusing on store-operated Ca 2+ entry (SOCE) and epithelium growth factor receptor (EGFR) transactivation.
Introduction
Vascular smooth muscle cells (VSMCs) play a central role in controlling vascular tone and maintaining the integrity of vessel wall. Under physiological conditions, VSMCs contraction and relaxation are regulated by biologically active mediators which are synthesized and secreted to modulate the vascular tone. Many of these mediators might play also a pathological role, and induce abnormal cellular proliferation during disease-related vascular remodelling. 1 Urotensin-II (UII) has emerged as a potent vasoconstrictor in different mammal species, including humans, and has been related to several cardiovascular diseases. 2, 3 The particular interest of the UII system relies into its 'quasi-irreversible' binding to a G-protein-coupled receptor (GPCR), known as a urotensin receptor (UTS2R). 4 UTS2R is functionally linked to Gq and phospholipase C (PLC), and its activation promotes long-term effects such as VSMCs proliferation. 4, 5 UII mediates VSMCs proliferation and † These authors contributed equally to this work remodelling through different signalling molecules such as ERK1/2 and RhoA/Rho kinase, 6 or via Ca 2+ /calmodulin-dependent kinase (CaMK). 7 Moreover, a recent study has implicated epidermal growth factor receptor (EGFR) transactivation and ERK phosphorylation in UII-induced rat aortic VSMCs proliferation. 8 Recently, we have determined that UII-induced rat coronary artery contraction involves [Ca 2+ ] i increase through the store-operated Ca 2+ entry (SOCE) pathway, which depends on the activation of the Ca 2+ -sensing regulatory protein stromal interaction molecule 1 (STIM1), and Orai1, the pore forming subunit of store-operated calcium channel (SOCC). 9 Only in recent years, the activation of the SOCE pathway has been associated with VSMCs proliferation. 10 -12 VSMCs switch from a 'contractile' to a 'synthetic' proliferative phenotype is regulated by a rise in [Ca 2+ ] i and by up or down-regulation of several SOCE-associated proteins as STIM1 and Orai1. 12, 13 Similar findings have been shown for some TRPC channels (TRPC1/3/5/6) that are activated by the sarcoplasmic reticulum depletion and suggested to be part of the endogenous SOCC.
14 Several reports have also demonstrated that SOCE is important for transcription factors activation that regulate the expression of many proliferating genes. Particularly, nuclear factor of activated T-cell (NFAT), or Ca 2+ /cAMP response element-binding protein (CREB) that are activated by Ca 2+ -induced phosphorylation. 15 -18 Additionally, CREB can be targeted by different signalling pathways, such as EGFR and ERK1/2, which promote VSMCs proliferation and/or hypertrophy. 18 Given the increasing importance of SOCE in VSMC proliferation and neointima formation, 13 this study sought to unveil the role of SOCE and the transcription of CREB in UII-mediated proliferation, taking in consideration the increasing interest regarding UII signalling mechanism and its relationship with cardiovascular disease. 3 
Methods
All the procedures of this study were approved by the Bioethical Committee of the Institute of Biomedicine of Seville (IBiS, Spain) in accordance with the animal care guidelines of the European Communities Council (86/609/EEC). An expanded Materials and Methods section detailing the protocols and techniques used in this study can be found in the Supplementary material online.
Primary aortic smooth muscle cell preparation
Adult male Wistar rats weighing 250 -350 g were heparinized (4 IU/g i.p.) and anaesthetized by i.p. administration of pentobarbital sodium overdose. Primary culture of aortic VSMCs was prepared following the same protocol as described previously. Figure 1A , both urantide (100 nM) and U73122 (50 mM) inhibited UII-induced Ca 2+ release and extracellular Ca
As illustrated in
Recently, we have demonstrated that UII-induced coronary artery vasoconstriction involves Ca 2+ entry through SOCC. 9 Here, we examined whether these channels participate in UII-mediated Ca 2+ entry in aortic VSMCs. Figure 1B shows that UII (100 nM) evoked a Ca 2+ influx, after re-addition of extracellular Ca 2+ (2 mM), similar to that typically induced by passive depletion of the intracellular store with thapsigargin (2 mM). As summarized in Figure 1B , UII-evoked Ca 2+ entry was blocked with classical inhibitors of SOCE, Gd 3+ (5-10 mM) and 2-aminoethoxydiphenyl borate (2APB) (75 mM). Furthermore, the addition of ML9 (25 and 50 mM) after Ca 2+ restoration also inhibited significantly the Ca 2+ influx elicited by UII, as shown in Figure 1C .
Next, to characterize the current mediating UII-induced SOCE in VSMCs, we tested if UII could activate CRAC channels in VSMCs. VSMCs have been demonstrated to start expressing whole-cell currents through CRAC channels (I CRAC -like current) after several passages in culture medium. 10 Whole-cell current was measured in a bath solution containing 20 mM Ca 2+ to determine Ca 2+ -I CRAC and was amplified using short pulses of standard divalent-free (DVF; Na + -I CRAC ) solutions. Figure 2A shows that cell dialysis with 150 nM free-Ca 2+ solution did not activate any inward current. Meanwhile, as shown in Figure 2B and summarized in Figure 2C and D, UII (1 mM) addition to the bath solution stimulated a significant inward Ca 2+ current that was amplified in DVF solution. Both developed inward currents, Ca 2+ -I CRAC and Na + -I CRAC , were sensitive to Gd 3+ (5 mM, Figure 2B ). The analysis of the currentvoltage (I-V ) curve for Ca 2+ -I CRAC ( Figure 2E ) and Na + -I CRAC ( Figure 2F ) confirms the inward rectification of UII-induced current, one of the features of I CRAC . Altogether, these data show for the first time that UII activates SOCE and I CRAC -like current in aortic VSMCs.
UII promotes VSMCs proliferation associated with a significant rise in SOCE
The effect of UII on VSMCs proliferation was assessed by BrdU incorporation. Figure 3A shows that VSMCs incubation with UII (100 nM) during 48 h promoted significant increase in BrdU positive marked cells. However, cell pre-treatment with SOCE blockers, ML9 (5 mM) and 2APB (50 mM), inhibited significantly VSMCs proliferation, which confirms SOCE role in UII proliferative effects. Cell proliferation has been associated with several intracellular Ca 2+ alterations with a great implication of SOCE. 10,14 So, we examined whether long-term incubation with UII could potentiate the rise in [Ca 2+ ] i mediated by SOCE.
Thapsigargin-activated SOCE was evaluated in serum-starved VSMCs treated 48 h with UII (100 nM) to mimic the same condition as in Figure 3A . As illustrated in Figure 3B , thapsigargin (2 mM) induced significantly higher responses in VSMCs incubated with UII comparing with untreated cells, which indicates that VSMCs proliferation is accompanied with a significant increase in SOCE. Next, we checked the expression of key proteins related to SOCE in UII-mediated proliferating VSMCs. Figure 3C shows that serum-starved cells treated with UII (100 nM during 48 h) presented significant increase in mRNA expression of STIM1 and Orai1 but not Orai3, whereas Orai2 expression was slightly decreased. In addition, TRPC1 that is believed to participate in the SOCE signalling pathway was also up-regulated in VSMCs treated with UII. These data confirm that proliferating VSMCs stimulated with UII show high degree of SOCE due apparently to the up-regulation of STIM1, Orai1, and TRPC1. Figure 4A ). Meanwhile, STIM1 and Orai1 knockdown with siRNA significantly decreased UII-induced Ca 2+ influx ( Figure 4A ). Moreover, Figure 4B and Supplementary material online, Figure SIB show that Orai1 and STIM1 down-regulation prevented VSMCs proliferation. These results confirm that STIM1 and Orai1 are implicated in UII-induced SOCE and VSMCs proliferation.
Evidence of TRPC1 participation in UII stimulation of calcium entry and VSMCs proliferation
Several reports have investigated the role of TRPC1 in SOCE in excitable and non-excitable cells. Here, we explored the potential participation of TRPC1 in Ca 2+ influx and VSMCs proliferation induced by UII. Figure 4A and C confirm that siRNA-mediated TRPC1 down-regulation in VSMCs significantly decreased UII-stimulated Ca 2+ entry and inhibited VSMCs proliferation, which suggests the participation of TRPC1 in this pathway. To understand the interaction between STIM1, Orai1, and TRPC1 in this complex signalling pathway, we studied the association between these proteins in VSMCs stimulated with either UII or thapsigargin to activate specifically SOCE. Figure 4D and E show that UII (100 nM) evoked a potent association between TRPC1 and Orai1, and between Orai1 and STIM1, respectively. Conversely, treatment of VSMCs with thapsigargin (2 mM) also promoted the interaction Figure 5A shows that UII (100 nM) activated EGFR phosphorylation 5 min after its addition which was sustained through 20 min of cells exposure to UII. EGFR phosphorylation was efficiently reduced in cells pre-treated with EGFR inhibitor AG1478 (100 nM, Figure 5A right). Furthermore, ERK activation is important for the EGFR signalling pathway; therefore, we determined ERK phosphorylation by UII. Figure 5B shows that ERK phosphorylation increased within 5 min of UII (100 nM) exposure and was sustained through 15 min of cells treatment. As shown in Figure 5B , the phosphorylation of ERK was potently inhibited by AG1478 (100 nM) and by ERK inhibitor PD98059 (10 mM). Next, we examined the role of SOCE in EGFR and ERK phosphorylation. As shown in Supplementary material online, Figure SII , 2APB (50 mM) and Figure 5C and D, the pre-incubation of VSMCs with AG1478 (100 nM) and PD98059 (10 mM) reduced significantly [Ca 2+ ] i increase and VSMCs proliferation. Moreover, a previous study has implicated CaMK in UII-induced pulmonary artery VSMCs proliferation. 7 Hence, we explored CaMKII implication in UII effects in aortic VSMCs using the specific inhibitor KN93. As shown in Supplementary material online, Figure SIIIA , pretreatment of cells with KN93 (2 mM) to block CaMKII inhibited significantly intracellular Ca 2+ influx induced by UII, and potently prevented VSMCs proliferation (Supplementary material online, Figure SIIIB) . These data confirm that UII effects in rat aorta VSMCs involve the transactivation of EGFR, ERK phosphorylation, and CaMKII signalling pathways. 
UII activates CREB phosphorylation through SOCE and EGFR transactivation
To highlight downstream pathways involved in UII-mediated SOCE of VSMCs proliferation and to elucidate the link between [Ca 2+ ] i increase and its effects on VSMCs proliferation, we focused on CREB contribution in UII effects. Figure 6A and Supplementary material online, Figure SIV show that VSMCs exposure during 5 min with different concentrations of UII significantly activated CREB. Next, SOCE role in CREB activation was examined. We found that SOCE pharmacological inhibition ( Figure 6B) , and knockdown of STIM1, Orai1, or TRPC1 ( Figure 6C ) significantly prevented UII-induced CREB activation, which Urotensin-II signalling and cells proliferation confirms the important role of SOCE. Furthermore, we studied the implication of EGFR, ERK, and CaMKII in CREB phosphorylation. Experiments shown in Figure 6D and Supplementary material online, Figure SIIIC demonstrate that all the inhibitors of these ones reduced significantly UII-mediated CREB activation, which indicates that UII activation of CREB involves SOCE and other signalling pathways. Finally, we explored the CREB role in VSMCs proliferation in cells transfected with siRNA against CREB. Figure 6E demonstrates that CREB silencing inhibited significantly UII-induced VSMCs proliferation suggesting the important role of CREB transcription in VSMCs proliferation.
Discussion
Several lines of evidence have demonstrated a major contribution of the UII system to cardiovascular diseases, metabolic syndrome, diabetes, or renal disease. 3, 23 UII acts as a chronic vasoactive regulator thanks to its 'pseudo-irreversible' binding and its slow-rate dissociation from the receptor, which leads to prolonged activation of UTS2R allowing longterm effects such as VSMCs proliferation. 5, 6 Here, we provide pharmacological and molecular data demonstrating the critical role of SOCE key proteins, such as STIM1, Orai1, and TRPC1, in UII-mediated VSMC proliferation. Moreover, our data confirm that UII effects are more complex in the rat coronary artery. 9 Here, we determine that UII addition to growth-arrested VSMCs stimulates their proliferation that is associated with an enhancement of thapsigargin-activated SOCE owing certainly to the up-regulation of STIM1, Orai1, and TRPC1. These results agree with previous studies which demonstrated that VSMCs switch from a 'contractile' to a 'synthetic' proliferative phenotype was associated with changes in the expression of proteins related to Ca 2+ homeostasis, such as CaV 2.1 channels, Orai1, TRPCs, or intracellular receptors. 14, 25 Our data confirm the relevant role of STIM1 and Orai1, in both UII-induced Ca 2+ influx and VSMCs proliferation, consistent with earlier studies that established the essential role of Orai1 and STIM1 for SOCE and the consequent VSMCs proliferation activated by different stimulus in rat aortic VSMCs.
-13
Importantly, we also demonstrate the involvement of TRPC1 in UII-stimulated Ca 2+ influx and VSMCs proliferation. The implication of TRPC1 in SOCE still remains under debate. 26 -28 Several groups have shown different interaction between proteins to form the SOCE signalling macromolecular complex (see reviews 29, 30 28 and recently in pulmonary arterial VSMCs. 32 Therefore, we believe that one of the most important findings in the present study is that upon UII application, Orai1 functionally and physically associates with STIM1 and TRPC1 in aortic VSMCs, which apparently form a macrocomplex signalling pathway that mediates [Ca 2+ ] i enhancement and further cell proliferation. Considerable interest has been focused towards the influence of ion channels plasticity and gene expression in VSMCs. It is well known that the sustained Ca 2+ influx through SOCC is crucial for transcriptional activation of CREB, which drives cellular proliferation through several proliferating genes. 15 In this study, we show that UII promotes CREB phosphorylation through SOCE which depends on STIM1, Orai1, and TRPC1 in accordance with previous studies, 11,17 although TRPC1
appeared not involved in angiotensin-II-induced VSMCs proliferation.
11 Importantly, we demonstrate that cells transfection with siRNA against CREB significantly inhibited cells proliferation, confirming the essential role of CREB activation for VSMCs proliferation. Moreover, in this report we confirm the implication of other signalling molecules in UII effects. We demonstrate that UII promotes EGFR transactivation, ERK activation, and CaMKII, similar to other GPCR agonists. We demonstrate that UII-evoked Ca 2+ entry, CREB activation, and
VSMCs proliferation are partially dependent on these signalling pathways in agreement with data shown in previous studies. 6 -8 Transactivation of EGFR seems a critical signalling step for some GPCR. 33 Similar results have been determined in VSMCs stimulated with hydrogen peroxide (H 2 O 2 ) which promotes EGFR transactivation and ERK1/2 stimulation followed by CREB phosphorylation. 34 Furthermore, we determine significantly diminished UII-mediated phosphorylation of EGFR and ERK due to SOCE inhibition. The role of extracellular Ca 2+ entry by SOCE has been linked to activation of the proliferative kinase ERK1/2 that is involved in cell proliferation and migration. 35 In addition, recents studies have demonstrated that epithelium growth factor (EGF) activation of EGFR stimulates SOCE in human mesangial cells, 36 or in cancer cell line, 37 which confirms the relevance and the need of further investigation to highlight the role of EGFR transactivation in VSMCs proliferation. As summarized in the schematic model in Supplementary material online, Figure SV , we have shown that UII promotes CREB activation and VSMCs proliferation through the multi-complex signalling pathway that involves SOCE, EGFR transactivation, ERK1/2, and CaMKII pathways. Our results shed more light on the functional role of UII in the arterial remodelling processes that occur during cardiovascular diseases, 23 and confirm different molecular players of SOCE as possible targets for therapeutic strategies to improve vascular occlusive diseases.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
